Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study

BMC Research Notes

Peter Martins Ndumbe¹  Peter Nde Fon¹  Julius Atashili¹  Andreas A Besong Frambo¹ 

[1] Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, P.O, Box, 63, Buea, Cameroon

关键词: Knowledge;    Cameroon;    Pregnancy;    HBsAg;    Prevalence;    Hepatitis B virus;   

Others  :  826579
DOI  :  10.1186/1756-0500-7-394

 received in 2013-04-11, accepted in 2014-06-20,  发布年份 2014

【 摘 要 】

Background

Although infection with Hepatitis B Virus (HBV) remains a global public health problem, little is known about its epidemiology in pregnancy in sub-Saharan Africa. This study sought to determine the prevalence of, and identify factors associated with hepatitis B surface antigen (HBsAg) positivity among pregnant women in the Buea Health District (BHD) in rural Cameroon. We also assessed pregnant women’s knowledge about hepatitis B.

Methods

A cross-sectional, descriptive study was undertaken. Participants were evaluated using a structured questionnaire with clinical examination and were then screened for HBsAg using a commercial rapid diagnostic test. Assessment of knowledge was done using a hepatitis B basic knowledge summary score.

Results

Of the 176 pregnant women studied, 9.7% (95% CI: 5.7%, 15%) tested positive for HBsAg. None of the risk factors assessed was significantly associated with HBsAg positivity. The hepatitis B knowledge summary score ranged from 0 to 12 with a mean of 1.5 (SD = 3.14, median = 0, IQR = 0 to 0). Only 16% of participants had scores greater than 6/12. The knowledge summary score of the participants was associated with the educational level (p-value = 0.0037).

Conclusion

The high prevalence of HBsAg (9.7%) among women of child bearing age suggests that vertical transmission of HBV may be a public health problem in Buea Health District. Knowledge of HBV among pregnant women was poor. We recommend that all pregnant women ought to be routinely screened for HBV and that health education on HBV should be provided to pregnant women especially during antenatal visits.

【 授权许可】

   
2014 Frambo et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]WHO: Hepatitis B. Fact Sheet No. 204. Geneva, Switzerland: World Health Organization; 2011.
• [2]Teo E-K, Lok ASF: Epidemiology, transmission, and prevention of hepatitis B virus infection. In UpToDate. Edited by Basow DS. Waltham, MA: UpToDate; 2009.
• [3]WHO: Hepatitis B vaccines. Relevé Épidémiologique Hebd Sect Hygiène Secrétariat Société Nations Wkly Epidemiol Rec Health Sect Secr Leag Nations 2004, 79:255-263.
• [4]Kramvis A, Kew MC: Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 2007, 37:S9-S19.
• [5]Fouelifack Ymele F, Keugoung B, Fouedjio JH, Kouam N, Mendibi S, Dongtsa Mabou J: High Rates of Hepatitis B and C and HIV Infections among Blood Donors in Cameroon: A Proposed Blood Screening Algorithm for Blood Donors in Resource-Limited Settings. J Blood Transfus 2012, 2012:1-7.
• [6]Noubiap JJN, Joko WYA, Nansseu JRN, Tene UG, Siaka C: Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis 2013, 17:e832-e837.
• [7]Euler GL, Wooten KG, Baughman AL, Williams WW: Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003, 111(Supplement 1):1192-1197.
• [8]Ndumbe PM, Andela A, Nkemnkeng-Asong J, Watonsi E, Nyambi P: Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon. Med Microbiol Immunol (Berl) 1992, 181:127-130.
• [9]Chiaramonte M, Stroffolini T, Ngatchu T, Rapicetta M, Lantum D, Kaptue L, Chionne P, Conti S, Sarrecchia B, Naccarato R: Hepatitis B virus infection in Cameroon: a seroepidemiological survey in city school children. J Med Virol 1991, 33:95-99.
• [10]Njouom R, Pasquier C, Ayouba A, Tejiokem MC, Vessiere A, Mfoupouendoun J, Tene G, Eteki N, Lobe MM, Izopet J: Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am J Trop Med Hyg 2005, 73:460-466.
• [11]Fomulu NJ, Morfaw FL, Torimiro JN, Nana P, Koh MV, William T: Prevalence, correlates and pattern of Hepatitis B among antenatal clinic attenders in Yaounde-Cameroon: is perinatal transmission of HBV neglected in Cameroon? BMC Pregnancy Childbirth 2013, 13:1-10. BioMed Central Full Text
• [12]Parry E, Godfrey R, Mabey D, Gill G: Hepatitis Viruses. In Princ Med Afr. 3rd edition. Cambridge: Cambridge University Press; 2009:710-712.
• [13]Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R, Verma M: Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol 2011, 30:66-71.
• [14]Obi SN, Onah HE, Ezugwu FO: Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population. J Obstet Gynecol 2006, 26:770-772.
• [15]Vázquez-Martínez JL, Coreño-Juárez MO, Montaño-Estrada LF, Attlan M, Gómez-Dantés H: Seroprevalencia de hepatitis B en mujeres embarazadas en México. Salud Pública México 2003, 45:165-170.
• [16]Ippolito AM, Niro GA, Fontana R, Lotti G, Gioffreda D, Valvano MR, Iacobellis A, Di Mauro L, Stroffolini T, Andriulli A: Unawareness of HBV infection among inpatients in a Southern Italian hospital. J Viral Hepat 2011, 18:e206-e211.
• [17]World Health Organization: Expanded Programme on Immunization. Protocol for Assessing Prevalence of Hepatitis B Infection in Antenatal Patients. Geneva: WHO; 1990. WHO/EPI/GEN/90.6
• [18]Thumamo PB, Asoquo AE: Hepatitis B Surface Antigen (HBsAg) in Female Students and Pregnant Women in the West Province of Cameroon. Mary Slessor J Med 2005, 4:53-57.
• [19]Kfutwah AK, Tejiokem MC, Njouom R: A low proportion of HBeAg among HBsAg-positive pregnant women with known HIV status could suggest low perinatal transmission of HBV in Cameroon. Virol J 2012, 9:422X-9.
• [20]Ndumbe PM, Skalsky J, Joller-Jemelka H: Seroprevalence of hepatitis and HIV infection among rural pregnant women in Cameroon. Apmis 1994, 102:662-666.
• [21]Okoth F, Mbuthia J, Gatheru Z, Murila F, Kanyingi F, Mugo F, Esamai F, Alavi Z, Otieno J, Kiambati H: Seroprevalence of hepatitis B markers in pregnant women in Kenya. East Afr Med J 2009, 83:485-493.
• [22]Makuwa M, Caron M, Souquière S, Malonga-Mouelet G, Mahé A, Kazanji M: Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol 2008, 46:754-756.
• [23]Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M: e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976, 294:746-749.
• [24]BEASLEY RP, TREPO C, STEVENS CE, SZMUNESS W: The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977, 105:94-98.
• [25]Wong VW, Reesink H, Ip HH, Nco Lelie P, Reerink-Brongers E, Yeung CY, Ma HK: Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: double-blind randomised placebo-controlled study. Lancet 1984, 323:921-926.
• [26]Borgia G, Carleo MA, Gaeta GB, Gentile I: Hepatitis B in pregnancy. World J Gastroenterol WJG 2012, 18:4677.
• [27]WHO: Hepatitis B. Immunization of newborn infants. Relevé Épidémiologique Hebd Sect Hygiène Secrétariat Société Nations Wkly Epidemiol Rec Health Sect Secr Leag Nations 1992, 67:208-210.
• [28]Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ: A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR 2005, 54:1-32.
• [29]Cisneros-Castolo M, Hernández-Ruiz L, Ibarra-Robles IE, Fernandez-Garate RH, Escobedo-De La Peña J: Prevalence of hepatitis B virus infection and related risk factors in a rural community of Mexico. Am J Trop Med Hyg 2001, 65:759-763.
• [30]Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO: Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstet Gynecol Scand 2010, 89:1024-1028.
• [31]Kitchen A: Hepatitis B and blood safety. Vaccine 1998, 16:S34-S37.
• [32]Tran TT: Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med 2009, 76(Suppl 3):S25-S29.
• [33]Borgia G, Gentile I: Treating chronic hepatitis B: today and tomorrow. Curr Med Chem 2006, 13:2839-2855.
• [34]Taylor VM, Jackson JC, Chan N, Kuniyuki A, Yasui Y: Hepatitis B knowledge and practices among Cambodian American women in Seattle, Washington. J Community Health 2002, 27:151-163.
• [35]Sharma R, Sharma CL, Khajuria R: The knowledge, attitude and practices regarding HBV infection of married women in the reproductive Age group living in cantonment Area Sunjawan Jammu. J Med Educ Res 2004, 6:127-130.
• [36]Talpur AA, Memon NA, Solangi RA, Ghumro AA: Knowledge and attitude of patients towards hepatitis B and C. Pak J Surg 2007, 23:162-165.
• [37]Cheung J, Lee TK, Teh C-Z, Wang CY, Kwan WC, Yoshida EM: Cross-sectional study of hepatitis B awareness among Chinese and Southeast Asian Canadians in the Vancouver-Richmond community. Can J Gastroenterol J Can Gastroenterol 2005, 19:245-249.